July 09, 2020 Medical device mergers on pause 2019 was an average year for medtech M&A. 2020, not so much.
June 23, 2020 Invitae ends medtech merger drought with ArcherDX deal The cash-and-stock deal, worth $886m up front, is the first major liquid biopsy acquisition since Roche bought Foundation Medicine.
